Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02918162
Title Perioperative Chemo and Pembrolizumab in Gastric Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Paul Oberstein
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Capecitabine + Epirubicin + Oxaliplatin + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.